These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 23861214)
1. Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer. Lou X; Qi X; Zhang Y; Long H; Yang J J Surg Oncol; 2013 Sep; 108(4):230-5. PubMed ID: 23861214 [TBL] [Abstract][Full Text] [Related]
2. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression. Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020 [TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK. Qin J; Luo M FEBS Lett; 2014 Jan; 588(1):99-104. PubMed ID: 24269686 [TBL] [Abstract][Full Text] [Related]
6. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer. Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance. Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523 [TBL] [Abstract][Full Text] [Related]
8. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Shen K; Liang Q; Xu K; Cui D; Jiang L; Yin P; Lu Y; Li Q; Liu J Biochem Pharmacol; 2012 Aug; 84(3):320-30. PubMed ID: 22580051 [TBL] [Abstract][Full Text] [Related]
9. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer. Zhang Y; He X; Liu Y; Ye Y; Zhang H; He P; Zhang Q; Dong L; Liu Y; Dong J Oncol Rep; 2012 Mar; 27(3):685-94. PubMed ID: 22134529 [TBL] [Abstract][Full Text] [Related]
10. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162 [TBL] [Abstract][Full Text] [Related]
13. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052 [TBL] [Abstract][Full Text] [Related]
14. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734 [TBL] [Abstract][Full Text] [Related]
15. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer. Shen F; Li J; Cai W; Zhu G; Gu W; Jia L; Xu B Oncol Rep; 2013 Sep; 30(3):1355-61. PubMed ID: 23784465 [TBL] [Abstract][Full Text] [Related]
16. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer. Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853 [TBL] [Abstract][Full Text] [Related]